Clinical Trial Update: Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating an allogeneic mesenchymal stem cell intraarticular injection for knee osteoarthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Allogeneic Mesenchymal Stem Cell intraarticular injection (mesenchymal stem cells)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: RECRUITING